Michael Altman

Michael Altman

Founder bij ARYA SCIENCES ACQUISITION CORP IV

Vermogen: 487 628 $ op 31-03-2024

42 jaar
Finance
Health Technology
Health Services

Profiel

Mr. Michael R.
Altman
, CFA MBA, is an Independent Director at Nautilus Biotechnology, Inc., a Chief Financial Office & Director at ARYA Sciences Acquisition Corp.
V, a Chief Financial Officer & Director at ARYA Sciences Acquisition Corp.
IV, an Independent Director at Lyra Therapeutics, Inc., a Managing Director at Perceptive Advisors LLC and a Managing Director at Perceptive Advisors (Private Equity).
He is on the Board of Directors at Nautilus Biotechnology, Inc., ARYA Sciences Acquisition Corp.
V, ARYA Sciences Acquisition Corp.
IV, Lyra Therapeutics, Inc., Vitruvias Therapeutics, Inc. and Covid Apollo Project LLC.
Mr. Altman was previously employed as a Chief Financial Officer & Director by ARYA Sciences Acquisition Corp.
III, a Chief Financial Officer & Director by ARYA Sciences Acquisition Corp.
II, a Chief Financial Officer & Director by ARYA Sciences Acquisition Corp., a Healthcare Analyst by First New York Securities LLC, and a Vice President by Mako Merger Sub, Inc. He also served on the board at Vensun Pharmaceuticals, Inc. He received his undergraduate degree from the University of Vermont.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-02-2024 165 860 ( 0.13% ) 487 628 $ 31-03-2024
01-03-2024 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Michael Altman

BedrijvenFunctieBegin
LYRA THERAPEUTICS, INC. Director/Board Member 01-06-2018
ARYA SCIENCES ACQUISITION CORP IV Founder 24-08-2020
NAUTILUS BIOTECHNOLOGY, INC. Director/Board Member 09-06-2021
ARYA SCIENCES ACQUISITION CORP V Founder 22-02-2021
Analyst-Fixed Income 01-10-2007
Director/Board Member -
Private Equity Analyst 01-01-2007
Director/Board Member -
Alle actieve functies van Michael Altman

Eerdere bekende functies van Michael Altman

BedrijvenFunctieEinde
ARYA SCIENCES ACQUISITION III A Founder 01-06-2021
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░ ░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Michael Altman in detail bekijken

Opleiding van Michael Altman

University of Vermont Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Michael Altman in detail bekijken

Connecties

100 +

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
LYRA THERAPEUTICS, INC.

Health Technology

ARYA SCIENCES ACQUISITION CORP IV

Finance

Bedrijven in privébezit12

Finance

Health Technology

Health Services

Finance

Finance

Finance

Finance

Finance

Finance

Nautilus Biotechnology, Inc.

Mako Merger Sub, Inc.

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Michael Altman